Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aminolevulinic acid/sodium ferrous citrate - SBI Pharmaceuticals

Drug Profile

Aminolevulinic acid/sodium ferrous citrate - SBI Pharmaceuticals

Alternative Names: 5-ALA-SFC; Sodium ferrous citrate/aminolevulinic acid; SPP-003

Latest Information Update: 28 Nov 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SBI Pharmaceuticals Co Ltd
  • Developer SBI Pharmaceuticals Co Ltd; University of Tokyo
  • Class Amino acids; Antianaemics; Antineoplastics; Keto acids; Levulinic acids; Oxidants; Small molecules
  • Mechanism of Action Erythropoiesis stimulants; Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Chemotherapy-induced anaemia
  • Research Mitochondrial disorders
  • No development reported Malaria; Type 2 diabetes mellitus

Most Recent Events

  • 28 Nov 2019 No recent reports of development identified for preclinical development in Malaria in Japan (PO)
  • 02 Aug 2019 Early research in Mitochondrial disorders in Japan (unspecified route)
  • 02 Aug 2019 Pharmacodynamics data from invitro study in Mitochondrial disorder released by SBI Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top